LXRX
Lexicon Pharmaceuticals Inc
Price:  
1.22 
USD
Volume:  
20,964,368.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LXRX EV/EBITDA

-785.9%
Upside

As of 2024-11-04, the EV/EBITDA ratio of Lexicon Pharmaceuticals Inc (LXRX) is -2.73. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. LXRX's latest enterprise value is 504.90 mil USD. LXRX's TTM EBITDA according to its financial statements is -185.06 mil USD. Dividing these 2 quantities gives us the above LXRX EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 9.7x - 17.3x 14.4x
Forward P/E multiples 15.2x - 17.7x 17.6x
Fair Price (7.96) - (9.02) (8.37)
Upside -752.3% - -839.6% -785.9%
1.22 USD
Stock Price
(8.37) USD
Fair Price

LXRX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-10-29 -4.31
2024-10-28 -3.98
2024-10-25 -3.86
2024-10-24 -3.94
2024-10-23 -3.98
2024-10-22 -4.13
2024-10-21 -4.15
2024-10-18 -4.41
2024-10-17 -4.27
2024-10-16 -4.08
2024-10-15 -3.84
2024-10-14 -3.84
2024-10-11 -3.74
2024-10-10 -3.65
2024-10-09 -3.53
2024-10-08 -3.63
2024-10-07 -3.63
2024-10-04 -3.65
2024-10-03 -3.49
2024-10-02 -3.49
2024-10-01 -3.43
2024-09-30 -3.41
2024-09-27 -3.47
2024-09-26 -3.35
2024-09-25 -3.29
2024-09-24 -3.41
2024-09-23 -3.43
2024-09-20 -3.59
2024-09-19 -3.65
2024-09-18 -3.55
2024-09-17 -3.51
2024-09-16 -3.53
2024-09-13 -3.67
2024-09-12 -3.61
2024-09-11 -3.65
2024-09-10 -3.61
2024-09-09 -3.61
2024-09-06 -3.49
2024-09-05 -3.51
2024-09-04 -3.53
2024-09-03 -3.49
2024-08-30 -3.72
2024-08-29 -3.86
2024-08-28 -3.70
2024-08-27 -3.70
2024-08-26 -3.80
2024-08-23 -3.92
2024-08-22 -3.92
2024-08-21 -4.08
2024-08-20 -3.63